FWO
Transcan-4 - European network on Translational Cancer Research
Last verified:
Transcan-4 funds high-impact translational cancer research through a European network coordinated by FWO, supporting Flemish partners in multinational consortia. Applicants must be based at an institution in Flanders, Belgium, and lead or co-lead a research team within a consortium of at least three entities from three EU member states. This is a consortium-based call emphasising pan-European collaboration on cancer translation from bench to clinic.
Details
| Funder | FWO |
| Consortium | Required — minimum 3 entities from 3 EU member states |
| Eligible countries | BE |
Eligibility & scope
Supports high-impact translational cancer research through the Transcan-4 European network. FWO funds the Belgian component of transnational consortia. Applicants must be affiliated with a Flemish research institution.
Who Should Apply
- •Researchers based at academic or hospital institutions in Flanders, Belgium
- •Established research groups with translational cancer expertise and international visibility
- •Teams ready to lead or co-lead a multinational cancer research consortium
- •Projects bridging fundamental oncology with clinical or pre-clinical applications
Key Dates
- •Consortium minimum: 3 entities from 3 EU member states required
- •Host institution must be located in Flanders, Belgium
Tips for Applicants
- ✓Consortium composition is non-negotiable; identify and commit your international partners early, FWO will not fund single-institution applications.
- ✓Emphasise the translational pathway and clinical relevance in your project narrative; Transcan-4 panels prioritise real-world cancer impact over fundamental novelty alone.
- ✓Secure a named coordinator or co-coordinator role; passive participation in someone else's consortium weakens a Flemish partner's competitiveness.
Frequently Asked Questions
Who is eligible to apply for Transcan-4?
Researchers based at institutions in Flanders, Belgium who are leading or co-leading a consortium of at least 3 entities from 3 different EU member states.
What is the minimum consortium size for Transcan-4?
At least 3 research entities from 3 different EU member states, with the FWO-funded Flemish partner(s) holding a substantive role.
Does Transcan-4 fund single-institution projects?
No; FWO only funds Flemish partners within transnational consortia structured around the Transcan-4 network.
Can researchers outside Flanders apply to FWO for Transcan-4?
No; the FWO-supported component is limited to researchers and institutions based in Flanders, Belgium, though they may partner with non-Belgian consortium members.
Related on Grantsby
- FWO writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from FWO
Baillet Latour Biomedical Award
Deadline: 14 Sept 2026€1,000,000 over 5 yearsSBO (Strategic Basic Research) projects
Deadline: 25 Sept 2026€45.5M total (guideline ~€1.7M excl. overhead per project; max €500k/year incl. overhead per legal entity)Odysseus Programme Type I
Deadline: 30 Sept 2026€2M–€3.5M (over 5 years)Marie Skłodowska-Curie Actions - Seal of Excellence Postdoctoral Fellowships
Raw Materials Partnership for the Green and Digital Transition (RAMP)
Browse Related
Could Transcan-4 - European network on Translational Cancer Research be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →